Almost every day, there are applications for pharmaceutical products and clinical trials from all over the country to be processed, which is also the responsibility of the staff in the bureau.
First of all, junior employees need to carefully review the application materials, including application forms, partial data of experiments or raw data and other documents. They also have to transfer work with various departments, as well as cooperate with pharmaceutical companies, research institutes, universities, etc. I have to say, this is a very busy job.
Moreover, the state has also issued mandatory punishment orders to all employees under the General Administration of Medicine, including leaders. Anyone who makes fun of their lives, accepts bribes without careful review, and endangers people's safety will be punished. There is no room for tolerance.
!
In the past, some leading cadres turned a blind eye to this prohibition, and corruption and greed emerged one after another. Later, all of them were dealt with, and their families were also implicated, and they were unable to enter the political career of the Dragon Kingdom for the rest of their lives.
In addition to the General Administration of Medicine, those who have this ban include military departments, science and technology departments, etc., but their punishments are more stringent than those of the General Administration of Medicine.
Whenever we find an example, we will uproot it!
In addition, in order to prevent collusion between government and business, the talents and relevant management recruited by the General Administration of Medicine every year are not allowed to be linked to businessmen or foreign capital. A comprehensive and in-depth review is carried out. Leading cadres are not allowed to work in any domestic company including foreign capital and joint ventures.
Hold any position within a pharmaceutical company or research institution, discover one, and handle one.
However, it is also necessary to attract high-quality and high-moral talents every year, and it also provides a lot of high benefits.
Some graduates from key universities majoring in medicine or biology are targeting recruitment by the General Administration of Medicine as soon as they graduate.
There are quite a few people who are dismissed every year.
In short, after various reforms, and with the Sword of Damocles always hanging over everyone's heads, some senior officials of the General Administration of Medicine have also restrained their little thoughts, and at the same time, they have created the current Longguo General Administration of Medicine in the hearts of the people.
Very high credibility image.
In the director's office, the current director of the General Administration of Medicine, Lu Tianming, is processing documents.
These documents are submitted by the director and staff after careful review. He only needs to check them again to see if there are any flaws. If there are no problems, they can pass the final approval.
However, applications like fast track or emergency track are generally submitted directly to the director of the bureau for review and then handed over to him for review.
I have to say that Lu Tianming’s hair has become a lot thinner after facing so much workload every day.
But fortunately, after working for a few more years, he should abdicate and make way for others.
"Let's keep working!"
Lu Tianming took a sip of wolfberry and red date water and continued to review the documents.
When it was the next application's turn, he found that the other party's application form said application for clinical trials of anti-cancer drugs - Shennong Pharmaceutical.
"Special anti-cancer drug? Is it the kind of bullshit plaster again?"
He has seen a lot of these applications over the years. Many companies claim to be anti-cancer in name, but in fact they have little effect. There are even certain text traps, which is a waste of application resources issued by the General Administration.
As a result, applications for such clinical trials began to be tightened.
All clinical applications for new drugs related to the treatment of major diseases must provide clinical trial data, which will be submitted to an expert group by the General Administration for review before the application can be issued.
The expert group randomly selects personnel from major tertiary hospitals or medical authoritative institutions across the country.
This is a necessary procedure. After all, he, as an administrator, does not understand the principles of experimental data and needs professionals to judge. Only through their reference can he have the authority to issue application approval documents.
Otherwise, the approval documents will be issued casually, and the consequences will be disastrous.
"Are the anti-cancer drugs here really effective? They cover four types of cancer lesions."
Lu Tianming was very suspicious. Although he was an administrator, he had also learned relevant knowledge and was naturally familiar with some medical knowledge.
"Forget it, there is nothing wrong with the other materials. Let's hand them over to the expert team for review according to normal procedures!"
He decided to let the experts of the expert group conduct a review first, otherwise no one would be able to bear the responsibility if something goes wrong.
Afterwards, Lu Tianming ordered his subordinates to call the application to the expert team.
Soon, the expert group was summoned and began regular review activities.
Some of the experts are experienced academicians, and some are technical experts. Their eyesight is like X-rays, scanning and identifying documents one after another, and sorting them into categories.
Applications placed in red boxes are rejected, while applications placed in green boxes are passed.
However, the red box is almost full of failed applications, while the green box has only a dozen or so approved applications.
This shows the strictness and rigor of the review.
"Huh? Here is a clinical application for an unnamed new anti-cancer drug. Take a look at this animal test data report."
Suddenly an expert said.
"Oh, in the past few years, some domestic companies have released specific anti-cancer drugs, and they even have the original data on animal testing. Let's take a look."
Zhu Weimin, who was in charge of this review, said "Oh" and curiously opened the application documents and materials.
As an academician and professor at Imperial Medical University, Zhu Weimin has taught many students and participated in many scientific research projects, some of which are national-level projects, so he still has considerable strength.
This time he came to receive an official invitation to review clinical trials, so he naturally agreed.
But I didn’t expect that in these review documents, there are actually anti-cancer drugs.
After reading it for a while, he couldn't help but be surprised.
Judging from the data of this animal test, there is no possibility of fraud, because they also have their own way of distinguishing true from false. This is a secret kept by the expert team.
"Shennong Pharmaceutical? I have never heard of this company!"
"Judging from this data, the animal experiment samples they conducted have many real proofs, and from a numerical point of view, they are within a controllable and safe range. I think we can apply for clinical trials."
"I think so, but to be on the safe side, we need to send people on-site to supervise the clinical trials to prevent any possibility of fraud."
"Then let's do it."
After discussion among a group of experts, the clinical application of Shennong Medicine was finally approved, and then it will be submitted to Lu Tianming for final approval and stamped.
After Lu Tianming received the feedback from the expert group, he immediately came over and approved the clinical trial application of Shennong Pharmaceutical.
Xu Li also received the news that the application was approved as soon as possible, and then asked Fang Mu and others to arrange the clinical experiment as soon as possible. The location was Meicheng Traditional Chinese Medicine Hospital.